| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/12/2014 | WO2014088123A1 Candesartan cilexetil-containing preparation |
| 06/12/2014 | WO2014087931A1 Aqueous ophthalmic composition |
| 06/12/2014 | WO2014087818A1 Orally administered liquid formulation |
| 06/12/2014 | WO2014087420A1 Oral gel for relief of tooth pain |
| 06/12/2014 | WO2014087419A1 Oral gel for sensitivity and tooth pain |
| 06/12/2014 | WO2014087413A1 Nanoparticles comprising sorafenib |
| 06/12/2014 | WO2014087410A1 Recognition-release nanoporous substrate comprising active agents, methods of their preparation and uses |
| 06/12/2014 | WO2014087394A1 Thrombin solution and methods of use thereof |
| 06/12/2014 | WO2014087325A1 Smart Coating for Implantable Devices |
| 06/12/2014 | WO2014087175A2 Droplet assembly by 3d printing |
| 06/12/2014 | WO2014087106A1 Solid dispersion of a selective modulator of the progesterone receptor |
| 06/12/2014 | WO2014087022A1 Protein slurp-1 for use in the treatment of ocular diseases |
| 06/12/2014 | WO2014086960A1 Triazine formulations with a second active ingredient and surfactant(s) |
| 06/12/2014 | WO2014086959A1 Treatment of coccidiosis with intramuscular triazine compositions |
| 06/12/2014 | WO2014086958A1 New treatments with triazines |
| 06/12/2014 | WO2014086893A1 Geopolymer hydrogels or suspensions and storage-stable granular mineral composites with colloidal portion, method for producing same and use thereof |
| 06/12/2014 | WO2014086857A1 Oral pharmaceutical composition comprising dabigatran etexilate |
| 06/12/2014 | WO2014086679A1 Biodegradable combination for treating diseases in which the intraocular pressure is elevated |
| 06/12/2014 | WO2014086104A1 Ampk activator and application thereof in preparing drugs for treating diabetes and/or diabetes complications |
| 06/12/2014 | WO2014085914A1 Topical liposome compositions containing phenolic anti-inflammatory agents and their methods of preparation |
| 06/12/2014 | WO2014085884A1 Pharmaceutical composition comprising desloratadine and prednisolone and use thereof |
| 06/12/2014 | WO2014064652A3 Stable pharmaceutical composition of peginterferon alpha-2b |
| 06/12/2014 | WO2014060988A3 Heating plaster for the treatment of punctures of jellyfish and other marine animals |
| 06/12/2014 | WO2014058179A3 Low-density lipoprotein analogue nanoparticles, and composition comprising same for targeted diagnosis and treatment of liver |
| 06/12/2014 | WO2014043385A3 Buffered microencapsulated compositions and methods |
| 06/12/2014 | WO2014039799A3 Photochemical activation of surfaces for attaching biomaterial |
| 06/12/2014 | WO2014009370A3 Core-shell capsules and methods for encapsulation including diffusion through spherical capsule membranes |
| 06/12/2014 | WO2013183068A9 Surfactant-copolymer complexes useful for sustained drug release |
| 06/12/2014 | WO2013097074A8 Method and improved pharmaceutical composition for enhancing transdermal delivery of pde-5 inhibitor |
| 06/12/2014 | WO2013080205A8 Jojoba extract useful in improving skin barrier functions |
| 06/12/2014 | WO2012153338A3 Liposomes comprising polymer-conjugated lipids and related uses |
| 06/12/2014 | US20140163366 Automatic Liquid Injection System and Method |
| 06/12/2014 | US20140163109 Taste-masked ibupropen granules |
| 06/12/2014 | US20140163108 Oral pharmaceutical dispersion compositions |
| 06/12/2014 | US20140163098 Compositions and methods for reducing body fat |
| 06/12/2014 | US20140163072 Method, composition and kit for treating frequent headaches |
| 06/12/2014 | US20140163060 Films and Drug Delivery Systems Made Therefrom |
| 06/12/2014 | US20140163057 Implantable Polymeric Device for Sustained Release of Buprenorphine |
| 06/12/2014 | US20140163051 Use and Application of a Pharmaceutical Composition Containing a Mixture of Natural-Origin Heterocyclical Guanidine, For Cosmetology, Wound Healing, Focal Dystonia and Muscular Spasm- Related Clinical Pathologies |
| 06/12/2014 | US20140163040 Pharmaceutical dosage form for immediate release of an indolinone derivative |
| 06/12/2014 | US20140162989 Multiple-component solid phases containing at least one active pharmaceutical ingredient |
| 06/12/2014 | US20140162982 Topical compositions for use in the prevention and/or treatment of dermatitis |
| 06/12/2014 | US20140162969 Microspheres for treatment of brain tumours |
| 06/12/2014 | US20140162959 Suspension type topical formulations comprising cyclic depdipeptide |
| 06/12/2014 | US20140162957 Lyophilized formulation of tat-nr2b9c |
| 06/12/2014 | US20140162953 Use of inhalable powder formulation comprising growth hormone for preventing or treating nmda receptor hypofunction-related diseases |
| 06/12/2014 | US20140162934 Novel lipids and compositions for intracellular delivery of biologically active compounds |
| 06/12/2014 | US20140161896 Particles for the treatment of neurodegenerative diseases |
| 06/12/2014 | US20140161893 Polymer blend particles for intracellular delivery of agents |
| 06/12/2014 | US20140161892 Nanoparticles comprising esters of poly (methyl vinyl ether-co-maleic anhydride) and uses thereof |
| 06/12/2014 | US20140161891 Composition of pi3k inhibitor and use thereof |
| 06/12/2014 | US20140161888 Formulations of 6-mercaptopurine |
| 06/12/2014 | US20140161887 Adjuvant compositions |
| 06/12/2014 | US20140161886 Mineral-coated microspheres |
| 06/12/2014 | US20140161882 Methods of therapeutic treatment of eyes and other human tissues using an oxygen-enriched solution |
| 06/12/2014 | US20140161881 Reduced dose pharmaceutical compositions of fenofibrate |
| 06/12/2014 | US20140161880 Sustained release tablet comprising pregabalin through two-phase release-controlling system |
| 06/12/2014 | US20140161879 Treating pain in patients with hepatic impairment |
| 06/12/2014 | US20140161876 Liposome-containing preparation utilizing dissolution aid, and method for producing same |
| 06/12/2014 | US20140161868 Transdermal delivery system kit |
| 06/12/2014 | US20140161867 Method of topically applying glycopyrrolate solution using absorbent pad to reduce sweating |
| 06/12/2014 | US20140161866 Structures and methods for delivering topical compositions |
| 06/12/2014 | US20140161864 Active formulation for use in feed products |
| 06/12/2014 | US20140161863 Drug delivery methods, structures, and compositions for nasolacrimal system |
| 06/12/2014 | US20140161860 Implantable Polymeric Device for Sustained Release of Buprenorphine |
| 06/12/2014 | US20140161854 Amphiphilic entity nanoparticles |
| 06/12/2014 | DE102013222457A1 Verfahren und system zum druck von personalisierten arzneimitteln Method and system for printing of personalized medicinal |
| 06/11/2014 | EP2740724A1 Compound for treating cartilage disorders |
| 06/11/2014 | EP2740532A1 Method of producing a starch-containing material |
| 06/11/2014 | EP2740492A1 Triazine formulations with a second active ingredient and surfactant(s) |
| 06/11/2014 | EP2740487A1 Alpha-i antitrypsin for treating exacerbation episodes of pulmonary diseases |
| 06/11/2014 | EP2740485A1 Protein SLURP-1 for use in the treatment of ocular diseases |
| 06/11/2014 | EP2740472A1 Patch and method for producing the same |
| 06/11/2014 | EP2740471A1 Oral pharmaceutical composition comprising dabigatran etexilate |
| 06/11/2014 | EP2740470A1 Treatment of Coccidiosis with intramuscular triazine composition |
| 06/11/2014 | EP2740469A1 New treatments with triazines |
| 06/11/2014 | EP2740468A1 Method for drug delivery and drug delivery systems |
| 06/11/2014 | EP2740458A1 Packaging comprising forms of sodium salt of 4-tert-butyl-N-[4-chloro-2-(1-oxy-pyridine-4-carbonyl)-phenyl]-benzenesulfonamide |
| 06/11/2014 | EP2739314A1 Pharmaceutical composition of oxidised avidin suitable for inhalation |
| 06/11/2014 | EP2739304A1 Particles for the treatment of neurodegenerative diseases |
| 06/11/2014 | EP2739303A2 A novel method for peroral delivery of insulin and its analogues for therapeutic usage |
| 06/11/2014 | EP2739291A2 Oxide ferrimagnetics with spinel structure nanoparticles and iron oxide nanoparticles, biocompatible aqueous colloidal systems comprising nanoparticles, ferriliposomes, and uses thereof |
| 06/11/2014 | EP2739288A2 Progesterone containing oral dosage forms and related methods |
| 06/11/2014 | EP2739276A1 Antiseptic composition |
| 06/11/2014 | EP2739275A1 Antiseptic composition |
| 06/11/2014 | EP2739273A1 Application aid |
| 06/11/2014 | EP2739272A1 Process for preparing pharmaceutical compositions comprising fingolimod |
| 06/11/2014 | EP2739271A1 Hydrophilic nanoparticles surface-modified with monosaccharide phosphate or monosaccharide phosphate derivatives, its colloidal solution and use thereof |
| 06/11/2014 | EP2739270A1 Non-digestible capsules for the delivery of fluid absorbing materials |
| 06/11/2014 | EP2739269A2 Dissolution enhanced controlled drug delivery system for poorly water soluble drugs |
| 06/11/2014 | EP2739268A1 Method and formulation for inhalation |
| 06/11/2014 | EP2739267A1 Pharmaceutical composition comprising factor vii encapsulated in micelles |
| 06/11/2014 | EP2739266A1 Stable anti-inflammatory solutions for injection |
| 06/11/2014 | EP2739265A1 Functionalized calcium phosphate artificial bone and joint compositions and methods of use and manufacture |
| 06/11/2014 | EP2739264A1 Pharmaceutical composition comprising ebastine and fluticasone |
| 06/11/2014 | CN203634514U 敷料贴裁切成型机 Dressing paste cutting machine |
| 06/11/2014 | CN203634513U 胶原蛋白口腔贴片 Collagen oral patch |
| 06/11/2014 | CN203634512U 一种新型消毒液配置罐 A new configuration of disinfectant tank |
| 06/11/2014 | CN103857412A Emulsified hydrogel composition and a production method therefor |
| 06/11/2014 | CN103857388A Compositions comprising salbutamol sulphate |